{
    "nctId": "NCT01765231",
    "officialTitle": "Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma",
    "inclusionCriteria": "* treatment-naive patients with lymphoma\n* HBsAg negative/HBcAb positive/hepatitis B virus DNA negative at baseline\n* treated with chemotherapy and/or immunosuppressive therapy\n* life expectancy of more than 3 months\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* younger than 18 years old\n* HBsAg positive or HBcAb negative or hepatitis B virus DNA positive at baseline\n* pregnant or lactating women"
}